EurekaMag
+ Translate
+ Most Popular
Advantages and disadvantages of bordeaux mixture and of lime-sulphur used on apples in the growing season
Observations on the Umaria marine bed
10 years of hearing conservation in the Royal Air Force
Chocolate crumb - dairy ingredient for milk chocolate
Effect of daily gelatin ingestion on human scalp hair
Comparison of rice bran and maize bran as feeds for growing and fattening pigs
The composition of pampas-grass (Cortaderia argentea.)
The Accraian Series:
The mechanism of the Liebermann-Burchard reaction of sterols and triterpenes and their esters
Cerebrovascular Doppler ultrasound studies (cv-Doppler)
Toria: PT-303 - first national variety
Hair growth promoting activity of tridax procumbens
Productivity of Pekin x Khaki Campbell ducks
A stable cytosolic expression of VH antibody fragment directed against PVY NIa protein in transgenic potato plant confers partial protection against the virus
Solar treatment of wheat loose smut
Swimmers itch in the Lake of Garda
Bactofugation and the Bactotherm process
The effects of prefrontal lobotomy on aggressive behavior in dogs
Visual rating scales for screening whorl-stage corn for resistance to fall armyworm
Breakdown of seamounts at the trench axis, viewed from gravity anomaly
Kooken; pennsylvania's toughest cave
Recovery of new dinosaur and other fossils from the Early Cretaceous Arundel Clay facies (Potomac Group) of central Maryland, U.S.A
Zubor horny (Bison bonasus) v prirodnych podmienkach Slovensku
The extended Widal test in the diagnosis of fevers due to Salmonella infection
Hair of the american mastodon indicates an adaptation to a semi aquatic habitat

Saccharomyces boulardii CNCM I-745 plus sequential therapy for Helicobacter pylori infections: a randomized, open-label trial


Saccharomyces boulardii CNCM I-745 plus sequential therapy for Helicobacter pylori infections: a randomized, open-label trial



European Journal of Clinical Pharmacology 75(5): 639-645



ISSN/ISBN: 0031-6970

PMID: 30694338

DOI: 10.1007/s00228-019-02625-0

To determine the effect of Saccharomyces boulardii CNCM I-745 (S. boulardii) plus sequential therapy on Helicobacter pylori (H. pylori) eradication rate. This open-label prospective study randomized (1:1) patients with confirmed H. pylori infection to standard sequential therapy of twice-daily (bid) omeprazole 20 mg plus amoxicillin 1 g for 5 days, followed by bid omeprazole 20 mg, clarithromycin 500 mg and metronidazole 500 mg for the next 5 days (control group), or sequential therapy plus bid S. boulardii 250 mg (experimental group). Adverse events (AEs) were recorded throughout the study, and the H. pylori eradication rate was determined 4 weeks after treatment. The study was conducted from May 2013 to May 2016 and included 199 patients (51.3% male; mean age 44.6 ± 13.6 years). The H. pylori eradication rate was higher in the experimental group than the control group (86.0% vs. 74.7%; P = 0.02). Compared with the control group, patients in the experimental group experienced a significantly lower overall incidence of AEs (17.0% vs. 55.7%; p < 0.001) and the incidence of antibiotic-associated diarrhea (2.0% vs. 46.4%; P = 0.02). The experimental group showed improved treatment compliance over the 10-day study period compared with the control group (95.0% vs. 91.2%, P < 0.001). Addition of S. boulardii to sequential therapy improved H. pylori eradication rate and reduced the incidence of treatment-associated AEs in Moroccan patients with H. pylori infection.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 066134307

Download citation: RISBibTeXText

Related references

Ten-day sequential versus triple therapy for Helicobacter pylori eradication: a prospective, open-label, randomized trial. Journal of Gastroenterology and Hepatology 27(11): 1675-1680, 2012

A randomized, open trial evaluating the effect of Saccharomyces boulardii on the eradication rate of Helicobacter pylori infection in children. Acta Paediatrica 98(1): 127-131, 2009

246 10-day Sequential Versus 10-day Bismuth-Containing Quadruple Therapy As Empirical First-Line Treatment for Helicobacter pylori: An Open Label Randomized Crossover Trial. Gastroenterology 144(5): S-54, 2013

Sequential Therapy for 10 Days Versus Triple Therapy for 14 Days in the First-line Treatment of Helicobacter pylori Infection A Multicenter, Open-label, Randomized Trial. Clinical Gastroenterology and Hepatology 12(1): 161-162, 2014

Propionibacterium/Cutibacterium species-related positive samples, identification, clinical and resistance features: a 10-year survey in a French hospital. European Journal of Clinical Microbiology and Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 39(7): 1357-1364, 2020

Saccharomyces boulardii as an adjuvant therapy for Helicobacter pylori eradication: A systematic review and meta-analysis with trial sequential analysis. References 24(5): E12651, 2019

Sa1932 Effect of Saccharomyces Boulardii Cncm I-745 on the Gut Microbiome As a Complementary Treatment Against Helicobacter Pylori Infection. Gastroenterology 156(6): S-458-S-459, 2019

The Efficacy of Saccharomyces boulardii CNCM I-745 in Addition to Standard Helicobacter pylori Eradication Treatment in Children. Pediatric Gastroenterology Hepatology and Nutrition 18(1): 17-22, 2015

Saccharomyces Boulardii in Helicobacter Pylori Eradication in Children: A Randomized Trial From Iran. Iranian Journal of Pediatrics 26(1): E3768, 2016

Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial. Lancet 381(9862): 205-213, 2013

M1119 Sequential Therapy vs. Standard Triple Therapy as Treatment of Helicobacter pylori Infection. A Prospective, Randomized, Parallel-Group, Open-Label Study in Mexico. Gastroenterology 138(5): S-336, 2010

Ten-day sequential versus triple therapy for H pylori eradication A prospective, open-label, randomized trial. 2012

Berberine containing quadruple therapy for initial Helicobacter pylori eradication: An open-label randomized phase IV trial. Medicine 96(32): E7697, 2017

Seven-Day Rifabutin Containing Triple Therapy Versus Seven-Day Levofloxacin Containing Quadruple Therapy As Second-Line Treatment for Helicobacter pylori in Chinese Patients: An Open Label, Randomized Trial. Gastroenterology 148(4): S-149, 2015

Stein Variational Gradient Descent with Matrix-Valued Kernels. Advances in Neural Information Processing Systems 32: 7834-7844, 2019